2196 related articles for article (PubMed ID: 7872665)
1. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in melanocytic lesions: a marker of malignant progression?
Harwood CA; Green MA; Cook MG
Br J Dermatol; 1996 Dec; 135(6):876-82. PubMed ID: 8977706
[TBL] [Abstract][Full Text] [Related]
3. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
[TBL] [Abstract][Full Text] [Related]
4. Suramin inhibits tumor cell cytotoxicity mediated through natural killer cells, lymphokine-activated killer cells, monocytes, and tumor necrosis factor.
LaPushin R; Totpal K; Higuchi M; Aggarwal BB
J Clin Immunol; 1994 Jan; 14(1):39-49. PubMed ID: 8132736
[TBL] [Abstract][Full Text] [Related]
5. In vivo detection of a boron-neutron-capture agent in melanoma by proton observed 1H-10B double resonance.
Bendel P; Zilberstein J; Salomon Y
Magn Reson Med; 1994 Aug; 32(2):170-4. PubMed ID: 7968438
[TBL] [Abstract][Full Text] [Related]
6. Expression of adhesion molecule CD44 in metastatic brain tumors.
Harabin-Słowińska M; Słowiński J; Konecki J; Mrówka R
Folia Neuropathol; 1998; 36(3):179-84. PubMed ID: 9833394
[TBL] [Abstract][Full Text] [Related]
7. Cytodiagnosis of malignant melanoma of soft tissue: report of a case with diagnosis by intraoperative cytology.
Ishi K; Suzuki F; Saito A; Koyatsu J; Kina K; Shitoto K
Acta Cytol; 1998; 42(5):1177-80. PubMed ID: 9755678
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.
Mohr P; Makki A; Breitbart E; Schadendorf D
Melanoma Res; 1998 Apr; 8(2):166-9. PubMed ID: 9610871
[TBL] [Abstract][Full Text] [Related]
9. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
Gould SW; Banwell PE; Rosin RD
Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
[TBL] [Abstract][Full Text] [Related]
10. Sun Smart Day: a pilot program for photoprotection education.
Buller MK; Goldberg G; Buller DB
Pediatr Dermatol; 1997; 14(4):257-63. PubMed ID: 9263304
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy.
Olencki T; Finke J; Tubbs R; Tuason L; Greene T; McLain D; Swanson SJ; Herzog P; Stanley J; Edinger M; Budd GT; Bukowski RM
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):69-80. PubMed ID: 8859726
[TBL] [Abstract][Full Text] [Related]
12. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity.
White VA; McNeil BK; Thiberville L; Horsman DE
Genes Chromosomes Cancer; 1996 Feb; 15(2):138-43. PubMed ID: 8834179
[TBL] [Abstract][Full Text] [Related]
13. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Goldin LR; Dracopoli NC; Clark WH; Tucker MA
Am J Hum Genet; 1996 May; 58(5):1050-6. PubMed ID: 8651266
[TBL] [Abstract][Full Text] [Related]
14. Malignant epithelioid schwannoma of the skin showing partial HMB-45 positivity.
Shimizu S; Teraki Y; Ishiko A; Shimizu H; Harada T; Mukai M; Nishikawa T
Am J Dermatopathol; 1993 Aug; 15(4):378-84. PubMed ID: 8214396
[TBL] [Abstract][Full Text] [Related]
15. Absence of p53 gene mutations in cutaneous melanoma.
Lübbe J; Reichel M; Burg G; Kleihues P
J Invest Dermatol; 1994 May; 102(5):819-21. PubMed ID: 8176269
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of cutaneous nevocarcinomas].
Banzet P; Belaich S; Civatte J; Puissant A; Jacquillat C; Israel L
J Chir (Paris); 1976 Mar; 111(3):347-54. PubMed ID: 956292
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous regression of cancer and the importance of finding its cause.
Cole WH
Natl Cancer Inst Monogr; 1976 Nov; 44():5-9. PubMed ID: 799760
[TBL] [Abstract][Full Text] [Related]
19. Perspective on allogeneic melanoma lysates in active specific immunotherapy.
Mitchell MS
Semin Oncol; 1998 Dec; 25(6):623-35. PubMed ID: 9865677
[TBL] [Abstract][Full Text] [Related]
20. Fine needle aspiration of signet-ring cell lymphoma. A case report with differential diagnostic considerations.
Gilcrease MZ; Sahin M; Perri RT; Nelson FS; Guzman-Paz M
Acta Cytol; 1998; 42(6):1461-7. PubMed ID: 9850663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
